Effect of I:E ratio on the respirable delivered dose from nebulizers

A. Metcalf (Chichester (West Sussex), United Kingdom), D. Von Hollen (Murraysville, United States of America), S. Cowley (Chichester (West Sussex), United Kingdom), L. Slator (Chichester (West Sussex), United Kingdom), L. Hardaker (Chichester (West Sussex), United Kingdom)

Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine
Session: Experimental and laboratory studies in intensive care unit medicine
Session type: E-poster session
Number: 2757
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Metcalf (Chichester (West Sussex), United Kingdom), D. Von Hollen (Murraysville, United States of America), S. Cowley (Chichester (West Sussex), United Kingdom), L. Slator (Chichester (West Sussex), United Kingdom), L. Hardaker (Chichester (West Sussex), United Kingdom). Effect of I:E ratio on the respirable delivered dose from nebulizers. 2757

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of I:E ratio on delivery of colistimethate sodium from breath-enhanced and breath-activated nebulizers
Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science
Year: 2013


Optimization of inhalation treatment – Evaluation of influence of spacer integrated with the spirometer on aerosol particle distribution from pMDI-EB
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I
Year: 2010


Effects on the respirable dose < 3.3 µm of an isotonic DSCG inhalation solution (IsoCROM) comparing different nebuliser systems mimicking 3 year old childrens' breathing patterns
Source: Eur Respir J 2007; 30: Suppl. 51, 460s
Year: 2007

Evaluation of delivered dose and treatment time of several mesh nebulizers under in vitro simulated use
Source: International Congress 2017 – Inhalers and their use
Year: 2017

Optimization of inhalation treatment – Assessment of the influence of diluent and air humidity on particle distribution of colistin administered by BCTS method [bronchial control treatment system]
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I
Year: 2010


Do dry powder inhalers (DPIs) have a ‘Goldilocks Zone’ of inhalation? In vitro lung deposition of Budesonide/Formoterol (BUD/FORM) DPI with different inhalation profiles
Source: International Congress 2017 – Pulmonary drug and devices delivery
Year: 2017

The impact of different valved holding chambers (VHCs) on lung drug delivery: using functional respiratory imaging (FRI) and a single metered dose inhaler (MDI) type
Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care
Year: 2020




Variability of budesonide (BUD) fine particle dose (FPD) delivered through two multiple dose dry powder inhalers (MDPI)
Source: Eur Respir J 2004; 24: Suppl. 48, 582s
Year: 2004

Effect of changes in peak inspiratory flow on the dose of salbutamol delivered by nebulizers under simulated conditions
Source: International Congress 2018 – What’s new in lung function and exercise assessment in COPD?
Year: 2018




Sub-microgram dose formulations for dose ranging studies with long acting bronchodilators and their fixed dose combination using metered dose inhalers (MDIs)
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013

A novel breath-actuated vortex spacer device increases respirable dose delivery of fluticasone/salmeterol in combination
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II
Year: 2008


Effect of breath-actuated mechanism on the emitted particle characteristics and lung deposition of a fixed combination drug
Source: International Congress 2017 – Inhalers and their use
Year: 2017

Ex-vivo emitted dose characteristics for combination formulations in dry powder inhalers (DPI)
Source: Eur Respir J 2003; 22: Suppl. 45, 472s
Year: 2003

Dose proportionality of in vitro fine particle dose for dry powder inhaler combination products
Source: Eur Respir J 2002; 20: Suppl. 38, 541s
Year: 2002

Effect of 3 different nebulisers on the aerosol delivery performance of isotonic disodium comoglycate (IsoCROM)
Source: Eur Respir J 2006; 28: Suppl. 50, 212s
Year: 2006

Does reduced dose volume impact inhaled mass with a novel low residual volume nebulizer?
Source: Eur Respir J 2003; 22: Suppl. 45, 147s
Year: 2003

Effect of device and formulation on delivery of budesonide suspensions by nebulizers
Source: Eur Respir J 2002; 20: Suppl. 38, 542s
Year: 2002

Effect of nebuliser position on aerosol performance during high flow nasal therapy
Source: International Congress 2018 – New tools for managing respiratory failure
Year: 2018


Delivered dose and fine particle dose of aclidinium bromide 200 µg via the Genuair® inhaler are independent of flow rate within the working range of the device
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I
Year: 2010


In vitro aerosol delivery by vibrating mesh nebulizer (VMN) and pressurized metered dose inhaler (pMDI) using spacers in comparison with T adapters in mechanical ventilation.
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020